COMPANY

VisCardia

HQ: Beaverton, OR source · viscardia.com ↗ · West Coast

Location: Beaverton, OR · source · Oct 14, 2026

Profile checked Oct 10, 2026

Keywords: Heart Failure With Reduced Ejection Fraction Heart Failure With Reduced Ejection Fraction, HFrEF Synchronized Diaphragmatic Stimulation VisONE ADS

$40.0MRaised (2 yrs)3Trials (company is sponsor)

Timeline

Jul 8, 2026 Trial start Not phased (device or behavioral study): Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure source ↗
Dec 2, 2025 Raise Private equity round — Growth Financing: $40M (total, as published), announced Dec 2, 2025. Source: company's own press page. source ↗ · Form D filed Oct 28, 2025 SEC Form D ↗
Aug 23, 2022 Trial start Not phased (device or behavioral study): RECOVER-HF Pilot Study of SDS in Heart Failure source ↗
Jul 25, 2018 Trial start Not phased (device or behavioral study): VisONE Heart Failure Study: Pilot source ↗

Upcoming milestones

2028-07 (ESTIMATED) · Not phased · Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure · NCT06552637

Estimated primary completion per ClinicalTrials.gov. Dates move.

Funding

Raised: $40.0M. Last 2 years.

Dec 2, 2025 Private equity round — Growth Financing: $40M (total, as published), announced Dec 2, 2025. Source: company's own press page. source ↗ · Form D filed Oct 28, 2025 SEC Form D ↗

Clinical trials (lead sponsor) 3

Record	Title	Phase	Status	Start	Primary completion
NCT06552637	Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure	Not phased (device or behavioral study)	Recruiting	Jul 8, 2026	2028-07 (estimated)
NCT05592392	RECOVER-HF Pilot Study of SDS in Heart Failure	Not phased (device or behavioral study)	Completed	Aug 23, 2022	Sep 30, 2024 (actual)
NCT03484780	VisONE Heart Failure Study: Pilot	Not phased (device or behavioral study)	Completed	Jul 25, 2018	Dec 12, 2019 (actual)